Does Bacterial Rhinitis Occur and What Is the Treatment?
Isolated bacterial rhinitis (infection of the nasal mucosa alone) essentially does not occur in clinical practice; what we actually see is acute bacterial rhinosinusitis (ABRS), where bacterial infection involves the paranasal sinuses with secondary nasal inflammation. 1
Understanding the Clinical Reality
The term "bacterial rhinitis" is a misnomer. The nasal mucosa has formidable multilayered host defenses that make infection with extracellular bacterial pathogens extremely rare 1. What clinicians encounter is:
- Viral rhinitis (the common cold) - the primary nasal infection
- Acute bacterial rhinosinusitis (ABRS) - bacterial superinfection of the sinuses that causes secondary nasal inflammation
- The condition should be termed "sinusitis complicated by rhinitis" or "toxic rhinitis complicated by bacterial infection" rather than true bacterial rhinitis 1
Diagnosing Acute Bacterial Rhinosinusitis
Diagnose ABRS when either of these criteria are met 2, 3:
- Symptoms persist ≥10 days beyond onset of upper respiratory symptoms without improvement
- "Double worsening" - symptoms initially improve then worsen again within 10 days
This distinction is critical because most acute rhinosinusitis cases are viral and resolve spontaneously without antibiotics 4.
Treatment Algorithm for ABRS
First-Line Antibiotic Therapy
Amoxicillin-clavulanate is the recommended first-line treatment (not amoxicillin alone) 2:
- Adults: Amoxicillin-clavulanate (weak recommendation, but preferred over amoxicillin alone)
- Children: Amoxicillin-clavulanate (strong recommendation)
- High-dose regimen: 2g orally twice daily (adults) or 90 mg/kg/day twice daily (children) when indicated 2
Duration of Treatment
Adjunctive Therapies
Recommended adjuncts 2:
- Intranasal saline irrigation (physiologic or hypertonic) - weak recommendation for adults
- Intranasal corticosteroids - especially in patients with allergic rhinitis history
- Analgesics - based on pain severity assessment
NOT recommended 2:
- Oral or topical decongestants
- Antihistamines
When to Reassess or Change Strategy
Switch management if 2:
- Symptoms worsen after 48-72 hours of antibiotics
- No improvement after 3-5 days of initial therapy
At this point, reassess to confirm ABRS diagnosis, exclude complications, and consider alternative pathogens.
Important Caveats
Do NOT routinely cover for Staphylococcus aureus or MRSA during initial empiric therapy, despite these being potential pathogens 2. Current evidence does not support routine coverage.
Avoid imaging unless you suspect complications or an alternative diagnosis 3. Clinical diagnosis is sufficient for uncomplicated ABRS.
Refer to specialists (ENT, infectious disease, allergist) when patients 2:
- Are seriously ill or immunocompromised
- Continue deteriorating despite extended antibiotic courses
- Have recurrent episodes with clearing between bouts